Anti-factor xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
Pabinger
Ingrid
I
Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria (Pabinger) Department of Transfusion Medicine, Institute for Immunology and Transfusion Medicine, University of Greifswald, Greifswald, Germany (Greinacher).
Greinacher
Andreas
A
D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000032:analysis*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood / Q000517:prevention & control*; D054556:Venous Thromboembolism / Q000097:blood / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D000990:Antithrombin III